Are you Dr. Hsu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
700 NE 87th Ave
Vancouver, WA 98664Phone+1 360-882-2778Fax+1 360-604-1753
Summary
- Dr. Pamela Hsu, MD is a cardiologist in Vancouver, Washington. She is currently licensed to practice medicine in Washington, Arizona, and California. She is affiliated with UNM Sandoval Regional Medical Center, Inc. and University of New Mexico Hospitals.
Education & Training
University of New Mexico School of MedicineFellowship, Cardiovascular Disease, 2000 - 2003
Kaiser Permanente Northern California (Oakland)Residency, Internal Medicine, 1997 - 2000- University of New Mexico School of MedicineInternship, Transitional Year, 1996 - 1997
- University of New Mexico School of MedicineClass of 1996
Certifications & Licensure
AZ State Medical License 2004 - Present
CA State Medical License 1998 - Present
NM State Medical License 1996 - 2027
WA State Medical License 2014 - 2019- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 1 citationsMyocarditis Presenting as ST-Elevation Myocardial Infarction.Fahad Hussain, Carmel Moazez, Kathleen Allen, Pamela Hsu, Kathryn Welch
Cureus. 2023-10-01 - 16 citationsDoppler evaluation of the descending aorta in patients with hypertrophic cardiomyopathy: potential for assessing the functional significance of outflow tract gradients...Steven Mickelsen, Murali N. Bathina, Pamela Hsu, Joanna Holmes, Fred Kusumoto
Journal of Interventional Cardiac Electrophysiology. 2004-08-01 - 2 citationsThe Year in Perioperative Echocardiography: Selected Highlights from 2018.Neal S. Gerstein, Christine Choi, Austin Henry, Pamela Y.F. Hsu, Swapnil Khoche
Journal of Cardiothoracic and Vascular Anesthesia. 2019-09-01
Press Mentions
Characterizing the Belinostat Response in Patients with Relapsed or Refractory Angioimmunoblastic T-cell LymphomaNovember 9th, 2019
